Related Experiment Videos
The dexamethasone suppression test in psychotic disorders
The American Journal of Psychiatry
|November 1, 1983
Summary
Dexamethasone suppression tests in psychiatric patients showed expected nonsuppression rates for depression and schizophrenia. However, higher-than-expected nonsuppression rates were observed in patients with mania and other psychoses.
Area of Science:
- Psychiatry
- Endocrinology
- Neuroscience
Background:
- The dexamethasone suppression test (DST) is a diagnostic tool used to evaluate hypothalamic-pituitary-adrenal (HPA) axis function.
- Abnormal DST results are associated with various psychiatric disorders, including depression, schizophrenia, and bipolar disorder.
Purpose of the Study:
- To assess the utility of the dexamethasone suppression test (DST) in a cohort of consecutively admitted psychiatric patients.
- To compare nonsuppression rates across different psychiatric diagnoses.
Main Methods:
- Sixty-nine consecutively admitted psychiatric patients underwent dexamethasone suppression testing.
- Nonsuppression rates were analyzed based on psychiatric diagnoses, including depression, schizophrenia, mania, and other psychoses.
Main Results:
- Nonsuppression rates for depression (with or without melancholia) and schizophrenia were consistent with previous research findings.
- A higher than anticipated frequency of nonsuppression was observed in patients diagnosed with mania and other psychoses.
Conclusions:
- The dexamethasone suppression test may have varying diagnostic utility across different psychiatric conditions.
- Further investigation is warranted to understand the elevated nonsuppression rates in mania and other psychoses, potentially indicating distinct HPA axis dysregulation patterns.